Centre proposes immediate suspension of licences for substandard drugs
The Health Ministry has introduced new regulations aimed at suspending manufacturing licenses for medicines that do not meet quality criteria. This swift action is intended to stop subpar drugs from reaching patients and to minimize their circulation during the regulatory review. Licenses can be suspended based on government analysts' findings that indicate deficiencies.
Full story
Read the full story at The Times of India ↗
Continue reading this story on The Times of India, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
